Tag Mylan

9 documents
Generic Drugs Compete in Game of Differentiation

Generic Drugs Compete in Game of Differentiation

Chain PHARMACY BY ALaRIC DEARMENT The year 2012 is coming to an end, and it’s been a big year for generic drugs. It’s the year that the most lucrative drug of…
Methyl Salicylate Patches Market 52 24marketreports

Methyl Salicylate Patches Market 52 24marketreports

This report presents a comprehensive overview of the Methyl Salicylate Patches market in Europe, which shares the history data information from 2012 to 2016, and…
Teijin et. al. v. Mylan Pharmaceuticals

Teijin et. al. v. Mylan Pharmaceuticals

Official Complaint for Patent Infringement in Civil Action No. 1:13-cv-01781-UNA: Teijin Limited et. al. v. Mylan Pharmaceuticals Inc. Filed in U.S. District Court…
Astrazeneca Ab et. al. v. Mylan Pharmaceuticals et. al.

Astrazeneca Ab et. al. v. Mylan Pharmaceuticals et. al.

Official Complaint for Patent Infringement in Civil Action No. 3:13-cv-06316-JAP-DEA: Astrazeneca Ab et. al. v. Mylan Pharmaceuticals et. al. Filed in U.S.…
Forest Laboratories et. al. v. Mylan et. al.

Forest Laboratories et. al. v. Mylan et. al.

Official Complaint for Patent Infringement in Civil Action No. 1:13-cv-01605-UNA: Forest Laboratories Inc. et. al. v. Mylan Inc. et. al. Filed in U.S. District…
Mylan Matrix Merger

Mylan Matrix Merger

Mylan Inc Background ã ã Mylan was the second-largest US generic drug maker as of 2006. The company is headquartered in Pennsylvania, USA, and is involved in…
HF-Case-Studies-Part-4-MYL-Stock-Pitch.docx

HF-Case-Studies-Part-4-MYL-Stock-Pitch.docx

Sample Hedge Fund Stock Pitch: Mylan [MYL] In this sample stock pitch outline, we’ll make a LONG (“Buy”) recommendation for Mylan [MYL] based on the results…
We Need Your Support
Thank you for visiting our website and your interest in our free products and services. We are nonprofit website to share and download documents. To the running of this website, we need your help to support us.

Thanks to everyone for your continued support.

No, Thanks